SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report [amend]
SEC Accession No. 0001104659-09-001842
Filing Date
2009-01-12
Accepted
2009-01-12 17:18:03
Documents
5
Period of Report
2008-01-30
Filing Date Changed
2009-01-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A a09-2620_18ka.htm 8-K/A 36095
2 EX-99.1 a09-2620_1ex99d1.htm EX-99.1 17036
3 EX-99.2 a09-2620_1ex99d2.htm EX-99.2 378094
4 GRAPHIC g26201mmi001.jpg GRAPHIC 3575
5 GRAPHIC g26201mmi002.jpg GRAPHIC 3595
  Complete submission text file 0001104659-09-001842.txt   443093
Mailing Address 1896 RUTHERFORD ROAD CARLSBAD CA 92008
Business Address 1896 RUTHERFORD ROAD CARLSBAD CA 92008 7609319200
ISIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

IRS No.: 330336973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-19125 | Film No.: 09522365
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1